October 21, 2019

Determining if your HUB should be insourced, outsourced, or a hybrid of those two options is a big decision. And finding the right answer can determine the future success of your patient access program.

July 23, 2019

Archbow's experience with program migrations has taught us what to anticipate, how to formulate realistic expectations, and where to find the right fit for teams needing a change. Q&A with Anna Beth Lindenmeyer

July 8, 2019

The entrance of cell and gene therapies into the market is impacting every corner of the industry. Likewise, the demand for high-quality CGT consulting services continues to grow with each passing day.

May 29, 2019

For cell and gene therapies, there's a marketplace shift happening from "Supply Chain" to "Demand Chain." Keep up with 8 vital elements of the new Demand Chain.

April 11, 2019

With the right approach, a good team, and a realistic timeline, pharma companies can successfully support their patients in new and exciting ways.

Please reload

Categories
Please reload

© 2019 by Archbow Consulting LLC | info@archbow.com(321) 355-2686

Privacy Policy